A novel low-energy electrotherapy that terminates ventricular tachycardia with lower energy than a biphasic shock when antitachycardia pacing fails.

OBJECTIVES The authors sought to develop a low-energy electrotherapy that terminates ventricular tachycardia (VT) when antitachycardia pacing (ATP) fails. BACKGROUND High-energy implantable cardioverter-defibrillator (ICD) shocks are associated with device failure, significant morbidity, and increased mortality. A low-energy alternative to ICD shocks is desirable. METHODS Myocardial infarction was created in 25 dogs. Sustained, monomorphic VT was induced by programmed stimulation. Defibrillation electrodes were placed in the right ventricular apex, and coronary sinus and left ventricular epicardium. If ATP failed to terminate sustained VT, the defibrillation thresholds (DFTs) of standard versus experimental electrotherapies were measured. RESULTS Sustained VT ranged from 276 to 438 beats/min (mean 339 beats/min). The right ventricular-coronary sinus shock vector had lower impedance than the right ventricular-left ventricular patch (54.4 ± 18.1 Ω versus 109.8 ± 16.9 Ω; p < 0.001). A single shock required between 0.3 ± 0.2 J to 5.9 ± 2.5 J (mean 2.64 ± 3.22 J; p = 0.008) to terminate VT, and varied depending upon the phase of the VT cycle in which it was delivered. By contrast, multiple shocks delivered within 1 VT cycle length were not phase dependent and achieved lower DFT compared with a single shock (0.13 ± 0.09 J for 3 shocks, 0.08 ± 0.04 J for 5 shocks, and 0.09 ± 0.07 J for 7 shocks; p < 0.001). Finally, a multistage electrotherapy (MSE) achieved significantly lower DFT compared with a single biphasic shock (0.03 ± 0.05 J versus 2.37 ± 1.20 J; respectively, p < 0.001). At a peak shock amplitude of 20 V, MSE achieved 91.3% of terminations versus 10.5% for a biphasic shock (p < 0.001). CONCLUSIONS MSE achieved a major reduction in DFT compared with a single biphasic shock for ATP-refractory monomorphic VT, and represents a novel electrotherapy to reduce high-energy ICD shocks.

[1]  B. Yashiro,et al.  Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. , 2011, Journal of the American College of Cardiology.

[2]  Y. Liao,et al.  Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome. , 2012, Journal of the American College of Cardiology.

[3]  S. Mittal,et al.  A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. , 2012, Journal of the American College of Cardiology.

[4]  Paul J. Wang,et al.  Reduction in life-threatening ventricular tachyarrhythmias in statin-treated patients with nonischemic cardiomyopathy enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). , 2012, Journal of the American College of Cardiology.

[5]  Lewis H Kuller,et al.  Risk factors for sudden cardiac death in post-menopausal women. , 2012, Journal of the American College of Cardiology.

[6]  S. Priori,et al.  Overexpression of CaMKIIδc in RyR2R4496C+/- knock-in mice leads to altered intracellular Ca2+ handling and increased mortality. , 2011, Journal of the American College of Cardiology.

[7]  J. Merino,et al.  Randomized, prospective comparison of four burst pacing algorithms for spontaneous ventricular tachycardia. , 1998, The American journal of cardiology.

[8]  T. Rea,et al.  Long-term prognosis following resuscitation from out of hospital cardiac arrest: role of percutaneous coronary intervention and therapeutic hypothermia. , 2012, Journal of the American College of Cardiology.

[9]  R. Cappato,et al.  Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation. , 2012, Journal of the American College of Cardiology.

[10]  Prashanthan Sanders,et al.  Pericardial fat is associated with atrial fibrillation severity and ablation outcome. , 2011, Journal of the American College of Cardiology.

[11]  Daniel R. Frisch,et al.  16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. , 2011, Journal of the American College of Cardiology.

[12]  A. Moss,et al.  Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator , 2004, Circulation.

[13]  Igor R Efimov,et al.  Multiple monophasic shocks improve electrotherapy of ventricular tachycardia in a rabbit model of chronic infarction. , 2009, Heart rhythm.

[14]  F. Crea,et al.  Transient impairment of vasomotion function after successful chronic total occlusion recanalization. , 2012, Journal of the American College of Cardiology.

[15]  E. Kaufman,et al.  Risk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndrome. , 2011, Journal of the American College of Cardiology.

[16]  Frédéric Sacher,et al.  Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance. , 2011, Journal of the American College of Cardiology.

[17]  Paul J. Wang,et al.  Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). , 2011, Journal of the American College of Cardiology.

[18]  D. Lin,et al.  Noninvasive programmed ventricular stimulation early after ventricular tachycardia ablation to predict risk of late recurrence. , 2012, Journal of the American College of Cardiology.

[19]  P. Platonov,et al.  Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. , 2011, Journal of the American College of Cardiology.

[20]  G. Lip,et al.  Inflammation in atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[21]  F. Cuoco Incidence and Predictors of Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Undergoing Implantable Cardioverter-Defibrillator Implantation for Primary Prevention , 2012 .

[22]  A. Camm,et al.  Nonsustained ventricular tachycardia. , 2012, Journal of the American College of Cardiology.

[23]  K. Kern Optimal treatment of patients surviving out-of-hospital cardiac arrest. , 2012, JACC. Cardiovascular interventions.

[24]  J. Dearani,et al.  Bioprosthetic tricuspid valve regurgitation associated with pacemaker or defibrillator lead implantation. , 2012, Journal of the American College of Cardiology.

[25]  Jeroen J. Bax,et al.  Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. , 2011, Journal of the American College of Cardiology.

[26]  H. Wellens,et al.  Sudden cardiac death , 2005 .

[27]  H. Pak,et al.  Antiarrhythmic potential of mesenchymal stem cell is modulated by hypoxic environment. , 2012, Journal of the American College of Cardiology.

[28]  G. Cho,et al.  Synchronicity of LV contraction as a determinant of LV twist mechanics: serial speckle-tracking analyses in WPW syndrome before and after radiofrequency catheter ablation. , 2011, JACC. Cardiovascular imaging.

[29]  Wojciech Zareba,et al.  Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator. , 2012, Journal of the American College of Cardiology.

[30]  M. Jiménez-Navarro,et al.  Factors predicting and having an impact on the need for a permanent pacemaker after CoreValve prosthesis implantation using the new Accutrak delivery catheter system. , 2012, JACC. Cardiovascular interventions.

[31]  Andrea Mazzanti,et al.  Long-term follow-up of patients with short QT syndrome. , 2011, Journal of the American College of Cardiology.

[32]  M. Keane,et al.  Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. , 2011, Journal of the American College of Cardiology.

[33]  F. Cuoco Dual-Chamber Implantable Cardioverter-Defibrillator Selection Is Associated With Increased Complication Rates and Mortality Among Patients Enrolled in the NCDR Implantable Cardioverter-Defibrillator Registry , 2012 .

[34]  H. Boyd,et al.  Familial aggregation of lone atrial fibrillation in young persons. , 2012, Journal of the American College of Cardiology.

[35]  A. Moss,et al.  Cardiac resynchronization and quality of life in patients with minimally symptomatic heart failure. , 2012, Journal of the American College of Cardiology.

[36]  O. Simonetti,et al.  Feasibility, accuracy, and reproducibility of real-time full-volume 3D transthoracic echocardiography to measure LV volumes and systolic function: a fully automated endocardial contouring algorithm in sinus rhythm and atrial fibrillation. , 2012, JACC. Cardiovascular imaging.

[37]  G. Stukenborg,et al.  Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death. , 2012, Journal of the American College of Cardiology.

[38]  D. Delurgio,et al.  Ventricular arrhythmia after cardiac surgery: incidence, predictors, and outcomes. , 2012, Journal of the American College of Cardiology.

[39]  R. Lazzara,et al.  Re‐entrant Ventricular Arrhythmias in the Late Myocardial Infarction Period: 4. Mechanism of Action of Lidocaine , 1977, Circulation.

[40]  W. Lehmacher,et al.  Impact of a new conduction defect after transcatheter aortic valve implantation on left ventricular function. , 2012, JACC. Cardiovascular interventions.

[41]  S. Priori,et al.  Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. , 2012, Journal of the American College of Cardiology.

[42]  N. El-Sherif,et al.  Reentrant ventricular arrhythmias in the late myocardial infarction period. II. Burst pacing versus multiple premature stimulation in the induction of reentry. , 1984, Journal of the American College of Cardiology.

[43]  G. Ginsburg,et al.  Clinical application of cardiovascular pharmacogenetics. , 2012, Journal of the American College of Cardiology.

[44]  R. Arriagada,et al.  Long-term cardiovascular mortality after radiotherapy for breast cancer. , 2011, Journal of the American College of Cardiology.

[45]  D. Rosenbaum,et al.  Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction. , 2012, Journal of the American College of Cardiology.

[46]  N. Freemantle,et al.  The limit of plausibility for predictors of response: application to biventricular pacing. , 2012, JACC. Cardiovascular imaging.

[47]  Niraj Varma,et al.  Differential response to cardiac resynchronization therapy and clinical outcomes according to QRS morphology and QRS duration. , 2012, Journal of the American College of Cardiology.

[48]  M. Conti,et al.  Cyclic adenosine monophosphate phosphodiesterase type 4 protects against atrial arrhythmias. , 2012, Journal of the American College of Cardiology.

[49]  Igor Klem,et al.  Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation , 2011, Journal of the American College of Cardiology.

[50]  A. Renzulli,et al.  Impact of lesion sets on mid-term results of surgical ablation procedure for atrial fibrillation. , 2011, Journal of the American College of Cardiology.

[51]  M. Brignole,et al.  New concepts in the assessment of syncope. , 2012, Journal of the American College of Cardiology.

[52]  P. D. del Nido,et al.  Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia. , 2011, Journal of the American College of Cardiology.

[53]  A. Schaumann,et al.  Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients. , 1998, Circulation.

[54]  A. Moss,et al.  Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis. , 2011, Journal of the American College of Cardiology.

[55]  P. Sanders,et al.  Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. , 2012, Journal of the American College of Cardiology.

[56]  P. Schwartz,et al.  Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. , 2012, Journal of the American College of Cardiology.

[57]  A. Boyle,et al.  The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. , 2011, Journal of the American College of Cardiology.

[58]  Michel Haïssaguerre,et al.  Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study. , 2011, Journal of the American College of Cardiology.

[59]  L. Mulligan,et al.  Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. , 2012, Journal of the American College of Cardiology.

[60]  Marco Merlo,et al.  Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. , 2011, Journal of the American College of Cardiology.

[61]  C. Tseng,et al.  Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). , 2012, Journal of the American College of Cardiology.

[62]  M. Nishizaki,et al.  Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia. , 2012, Journal of the American College of Cardiology.

[63]  W. Stevenson,et al.  Misleading long post-pacing interval after entrainment of typical atrial flutter from the cavotricuspid isthmus. , 2012, Journal of the American College of Cardiology.

[64]  Gregory Y H Lip,et al.  Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. , 2011, Journal of the American College of Cardiology.

[65]  Matthew Wright,et al.  Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? , 2011, Journal of the American College of Cardiology.

[66]  J. Dearani,et al.  Outcome of cardiac surgery in patients 50 years of age or older with Ebstein anomaly: survival and functional improvement. , 2012, Journal of the American College of Cardiology.

[67]  Igor R Efimov,et al.  Panoramic imaging reveals basic mechanisms of induction and termination of ventricular tachycardia in rabbit heart with chronic infarction: implications for low-voltage cardioversion. , 2009, Heart rhythm.

[68]  P. Heidenreich,et al.  Payment source, quality of care, and outcomes in patients hospitalized with heart failure. , 2011, Journal of the American College of Cardiology.

[69]  Wojciech Zareba,et al.  Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. , 2008, Journal of the American College of Cardiology.

[70]  J. Jollis,et al.  Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial. , 2012, Journal of the American College of Cardiology.

[71]  K. Ellenbogen,et al.  Preventing overdiagnosis of implantable cardioverter-defibrillator lead fractures using device diagnostics. , 2011, Journal of the American College of Cardiology.

[72]  E. Prystowsky,et al.  Ventricular arrhythmias in the absence of structural heart disease. , 2012, Journal of the American College of Cardiology.

[73]  D. Roden,et al.  Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[74]  Prashanthan Sanders,et al.  Epistatic effects of potassium channel variation on cardiac repolarization and atrial fibrillation risk. , 2012, Journal of the American College of Cardiology.

[75]  S. Hunziker,et al.  Teamwork and leadership in cardiopulmonary resuscitation. , 2011, Journal of the American College of Cardiology.

[76]  H. Calkins,et al.  Superiority of simulator-based training compared with conventional training methodologies in the performance of transseptal catheterization. , 2011, Journal of the American College of Cardiology.

[77]  L. Køber,et al.  Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study. , 2012, Journal of the American College of Cardiology.

[78]  Wouter-Jan Rappel,et al.  Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. , 2012, Journal of the American College of Cardiology.

[79]  J. McMurray,et al.  Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study. , 2012, Journal of the American College of Cardiology.

[80]  M. Brignole,et al.  Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant. , 2012, Journal of the American College of Cardiology.

[81]  Jeroen J. Bax,et al.  Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders. , 2011, Journal of the American College of Cardiology.

[82]  S. Bielinski,et al.  Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[83]  J. Schulz-Menger,et al.  Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR. , 2011, JACC. Cardiovascular imaging.

[84]  Daniel R. Frisch,et al.  Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. , 2012, Journal of the American College of Cardiology.

[85]  G. Salama,et al.  Subthreshold stimulation of Purkinje fibers interrupts ventricular tachycardia in intact hearts. Experimental study with voltage-sensitive dyes and imaging techniques. , 1994, Circulation research.

[86]  H. Crijns,et al.  Effect of lenient versus strict rate control on cardiac remodeling in patients with atrial fibrillation data of the RACE II (RAte Control Efficacy in permanent atrial fibrillation II) study. , 2011, Journal of the American College of Cardiology.

[87]  J. Dearani,et al.  Congenitally corrected transposition of the great arteries ventricular function at the time of systemic atrioventricular valve replacement predicts long-term ventricular function. , 2011, Journal of the American College of Cardiology.

[88]  J. Piccini,et al.  Device therapy in heart failure patients with chronic kidney disease. , 2011, Journal of the American College of Cardiology.

[89]  N. Freemantle,et al.  Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses. , 2011, Journal of the American College of Cardiology.

[90]  G. Boriani,et al.  Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. , 2011, Journal of the American College of Cardiology.

[91]  R. Waksman,et al.  Hypothermia therapy: neurological and cardiac benefits. , 2012, Journal of the American College of Cardiology.

[92]  M. Bonini,et al.  Inhibition of c-Src tyrosine kinase prevents angiotensin II-mediated connexin-43 remodeling and sudden cardiac death. , 2011, Journal of the American College of Cardiology.

[93]  H. Trappe,et al.  Clinical Efficacy and Safety of the New Cardioverter Defibrillator Systems , 1993, Pacing and clinical electrophysiology : PACE.

[94]  Sanjiv M. Narayan,et al.  Atrial conduction slows immediately before the onset of human atrial fibrillation: a bi-atrial contact mapping study of transitions to atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[95]  Dixon Magnuson,et al.  Effective use of radiation shields to minimize operator dose during invasive cardiology procedures. , 2011, JACC. Cardiovascular interventions.

[96]  G. Lip,et al.  New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. , 2012, Journal of the American College of Cardiology.

[97]  Juan Pablo Martínez,et al.  Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology. , 2011, Journal of the American College of Cardiology.

[98]  Kurt S. Hoffmayer,et al.  Electrocardiographic comparison of ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract tachycardia. , 2011, Journal of the American College of Cardiology.

[99]  M. Gollob,et al.  The short QT syndrome: proposed diagnostic criteria. , 2011, Journal of the American College of Cardiology.

[100]  Judy Powell,et al.  Quality of Life in the Antiarrhythmics Versus Implantable Defibrillators Trial: Impact of Therapy and Influence of Adverse Symptoms and Defibrillator Shocks , 2002, Circulation.

[101]  Eric A. Shry,et al.  Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. , 2011, Journal of the American College of Cardiology.

[102]  A. Natale,et al.  Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation. , 2012, Journal of the American College of Cardiology.

[103]  H. Crijns,et al.  The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study. , 2011, Journal of the American College of Cardiology.

[104]  L. Lai,et al.  Mechanical stretch of atrial myocyte monolayer decreases sarcoplasmic reticulum calcium adenosine triphosphatase expression and increases susceptibility to repolarization alternans. , 2011, Journal of the American College of Cardiology.

[105]  W. Stevenson,et al.  Ventricular scars and ventricular tachycardia. , 2009, Transactions of the American Clinical and Climatological Association.

[106]  A. Moss,et al.  Effect of cardiac resynchronization therapy on the risk of first and recurrent ventricular tachyarrhythmic events in MADIT-CRT. , 2012, Journal of the American College of Cardiology.

[107]  R. Hauer,et al.  Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. , 2012, Journal of the American College of Cardiology.

[108]  M. Faouzi,et al.  New electrocardiographic criteria for discriminating between Brugada types 2 and 3 patterns and incomplete right bundle branch block. , 2011, Journal of the American College of Cardiology.

[109]  B. Desjardins,et al.  Septal involvement in patients with post-infarction ventricular tachycardia: implications for mapping and radiofrequency ablation. , 2011, Journal of the American College of Cardiology.

[110]  C. Antzelevitch,et al.  Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations. , 2011, Journal of the American College of Cardiology.

[111]  R. Brook,et al.  The effect of air pollution on spatial dispersion of myocardial repolarization in healthy human volunteers. , 2011, Journal of the American College of Cardiology.

[112]  Suneet Mittal,et al.  Ambulatory external electrocardiographic monitoring: focus on atrial fibrillation. , 2011, Journal of the American College of Cardiology.

[113]  Paul J. Wang,et al.  Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). , 2011, Journal of the American College of Cardiology.

[114]  M. Eldar,et al.  Left atrial contractile function following a successful modified Maze procedure at surgery and the risk for subsequent thromboembolic stroke. , 2011, Journal of the American College of Cardiology.

[115]  Dan M Roden,et al.  Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia. , 2012, Journal of the American College of Cardiology.

[116]  D. Lin,et al.  The V(2) transition ratio: a new electrocardiographic criterion for distinguishing left from right ventricular outflow tract tachycardia origin. , 2011, Journal of the American College of Cardiology.

[117]  C. Stefanadis,et al.  Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study. , 2012, Journal of the American College of Cardiology.

[118]  Omer Berenfeld,et al.  Mechanisms of fractionated electrograms formation in the posterior left atrium during paroxysmal atrial fibrillation in humans. , 2011, Journal of the American College of Cardiology.

[119]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[120]  E. Kholmovski,et al.  Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. , 2011, Journal of the American College of Cardiology.

[121]  V. Reddy,et al.  Activation and entrainment mapping of hemodynamically unstable ventricular tachycardia using a percutaneous left ventricular assist device. , 2011, Journal of the American College of Cardiology.

[122]  M. Mack,et al.  Medical device innovation: prospective solutions for an ecosystem in crisis. Adding a professional society perspective. , 2012, JACC. Cardiovascular interventions.

[123]  G. Lip,et al.  Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[124]  Mark A. Wood,et al.  Histopathologic characterization of chronic radiofrequency ablation lesions for pulmonary vein isolation. , 2012, Journal of the American College of Cardiology.

[125]  A. Auricchio,et al.  Feasibility and acute efficacy of radiofrequency ablation of cavotricuspid isthmus-dependent atrial flutter guided by real-time 3D TEE. , 2011, JACC Cardiovascular Imaging.

[126]  Michael Glikson,et al.  Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells. , 2012, Journal of the American College of Cardiology.

[127]  G. Guiraudon,et al.  Initial clinical experience with the pacemaker-cardioverter-defibrillator. , 1990, The Canadian journal of cardiology.

[128]  M. Bernard Impact of Implanted Recalled Sprint Fidelis Lead on Patient Mortality , 2012 .

[129]  J. Seward,et al.  Diastolic dysfunction in patients undergoing cardiac surgery: a pathophysiological mechanism underlying the initiation of new-onset post-operative atrial fibrillation. , 2011, Journal of the American College of Cardiology.

[130]  N Engl,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.

[131]  P. Pibarot,et al.  Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. , 2012, Journal of the American College of Cardiology.

[132]  V. Salomaa,et al.  The early repolarization pattern in the general population: clinical correlates and heritability. , 2011, Journal of the American College of Cardiology.

[133]  H. Nakagawa,et al.  Prevention and reversal of atrial fibrillation inducibility and autonomic remodeling by low-level vagosympathetic nerve stimulation. , 2011, Journal of the American College of Cardiology.

[134]  Michael O. Sweeney,et al.  Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients With Coronary Artery Disease , 2001, Circulation.

[135]  M. Haissaguerre,et al.  Dynamicity of the J-wave in idiopathic ventricular fibrillation with a special reference to pause-dependent augmentation of the J-wave. , 2012, Journal of the American College of Cardiology.

[136]  P. Pais,et al.  The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy. , 2011, Journal of the American College of Cardiology.

[137]  G. De Luca,et al.  Effects of increasing doses of intracoronary adenosine on the assessment of fractional flow reserve. , 2011, JACC. Cardiovascular interventions.

[138]  E. Vittinghoff,et al.  Sudden cardiac death in patients with human immunodeficiency virus infection. , 2012, Journal of the American College of Cardiology.

[139]  Jeroen J. Bax,et al.  Left atrial strain predicts reverse remodeling after catheter ablation for atrial fibrillation. , 2011, Journal of the American College of Cardiology.

[140]  P. Schwartz,et al.  Spectrum and Prevalence of Mutations Involving Brs1-through Brs12-susceptibility Genes in a Cohort of Unrelated Patients Referred for Brugada Syndrome Genetic Testing Implications for Genetic Testing , 2022 .

[141]  Dhanunjaya R. Lakkireddy,et al.  Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. , 2012, Journal of the American College of Cardiology.

[142]  E. Behr,et al.  Low prevalence of risk markers in cases of sudden death due to Brugada syndrome relevance to risk stratification in Brugada syndrome. , 2011, Journal of the American College of Cardiology.

[143]  J. Weiss,et al.  Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine. , 2011, Journal of the American College of Cardiology.

[144]  H. Tan,et al.  Incidence, causes, and outcomes of out-of-hospital cardiac arrest in children. A comprehensive, prospective, population-based study in the Netherlands. , 2011, Journal of the American College of Cardiology.

[145]  F. Marín,et al.  Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. , 2011, Journal of the American College of Cardiology.

[146]  L. Ling,et al.  Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. , 2012, Journal of the American College of Cardiology.

[147]  Y. Ohashi,et al.  Alcohol consumption and risk of atrial fibrillation: a meta-analysis. , 2011, Journal of the American College of Cardiology.

[148]  J. Healey,et al.  Clinical ResearchHeart Rhythm DisorderPrevalence and Characteristics of Early Repolarization in the CASPER Registry: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry , 2011 .

[149]  B. Fetics,et al.  Transient local injury current in right ventricular electrogram after implantable cardioverter-defibrillator shock predicts heart failure progression. , 2009, Journal of the American College of Cardiology.

[150]  Elena Arbelo,et al.  Noninvasive identification of ventricular tachycardia-related conducting channels using contrast-enhanced magnetic resonance imaging in patients with chronic myocardial infarction: comparison of signal intensity scar mapping and endocardial voltage mapping. , 2011, Journal of the American College of Cardiology.

[151]  Kevin L. Thomas,et al.  Systematic review of the incidence of sudden cardiac death in the United States. , 2011, Journal of the American College of Cardiology.

[152]  K. Kuck,et al.  Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy. , 2012, Journal of the American College of Cardiology.

[153]  Stefan A. Mann,et al.  Genetics and Genomics R222q Scn5a Mutation Is Associated with Reversible Ventricular Ectopy and Dilated Cardiomyopathy , 2022 .

[154]  Martin J Schalij,et al.  Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. , 2011, Journal of the American College of Cardiology.

[155]  Y. Akutsu,et al.  Iodine-123 mIBG Imaging for Predicting the Development of Atrial Fibrillation. , 2011, JACC. Cardiovascular imaging.

[156]  A. Zwinderman,et al.  Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. , 2012, Journal of the American College of Cardiology.

[157]  Michael F Swartz,et al.  Elevated pre-operative serum peptides for collagen I and III synthesis result in post-surgical atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[158]  E. Sideris,et al.  Transcatheter patch occlusion of the left atrial appendage using surgical adhesives in high-risk patients with atrial fibrillation. , 2011, Journal of the American College of Cardiology.

[159]  J. Kingdom,et al.  Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses. , 2011, Journal of the American College of Cardiology.

[160]  G. Lip,et al.  Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk. , 2011, Journal of the American College of Cardiology.

[161]  S. Mittal,et al.  The federal audit of implantable cardioverter-defibrillator implants: lessons learned. , 2012, Journal of the American College of Cardiology.

[162]  C. Albert,et al.  Type 2 diabetes mellitus and risk of incident atrial fibrillation in women. , 2012, Journal of the American College of Cardiology.

[163]  L. Jordaens,et al.  The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. , 2012, Journal of the American College of Cardiology.

[164]  S. Einav,et al.  Modeling serum biomarkers S100 beta and neuron-specific enolase as predictors of outcome after out-of-hospital cardiac arrest: an aid to clinical decision making. , 2012, Journal of the American College of Cardiology.

[165]  S. Solomon,et al.  Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. , 2011, Journal of the American College of Cardiology.

[166]  N. Silverman,et al.  Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. , 2011, Journal of the American College of Cardiology.

[167]  Yutao Guo,et al.  Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study. , 2012, Journal of the American College of Cardiology.

[168]  R. Luceri,et al.  Changing Trends in Therapy Delivery with a Third Generation Noncommitted Implantable Defibrillator: Results of a Large Single Center Clinical Trial , 1993, Pacing and clinical electrophysiology : PACE.

[169]  M. Christiansen,et al.  Family history of premature death and risk of early onset cardiovascular disease. , 2012, Journal of the American College of Cardiology.

[170]  D. Mozaffarian,et al.  Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. , 2011, Journal of the American College of Cardiology.

[171]  Michael Salerno,et al.  MR cine DENSE dyssynchrony parameters for the evaluation of heart failure: comparison with myocardial tissue tagging. , 2012, JACC. Cardiovascular imaging.

[172]  Laurent Pison,et al.  Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[173]  Jørgen K. Kanters,et al.  In silico cardiac risk assessment in patients with long QT syndrome: type 1: clinical predictability of cardiac models. , 2012, Journal of the American College of Cardiology.

[174]  A. Moss,et al.  Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). , 2011, Journal of the American College of Cardiology.

[175]  D. Mark,et al.  Prognostic importance of defibrillator shocks in patients with heart failure. , 2008, The New England journal of medicine.

[176]  J. Oss,et al.  IMPROVED SURVIVAL WITH AN IMPLANTED DEFIBRILLATOR IN PATIENTS WITH CORONARY DISEASE AT HIGH RISK FOR VENTRICULAR ARRHYTHMIA , 1996 .

[177]  Alessandro Cristoforetti,et al.  Anatomic localization of rapid repetitive sources in persistent atrial fibrillation: fusion of biatrial CT images with wave similarity/cycle length maps. , 2012, JACC. Cardiovascular imaging.

[178]  A. Wilde,et al.  Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. , 2011, Journal of the American College of Cardiology.

[179]  B. Raju,et al.  Monomorphic ventricular tachycardia and mediastinal adenopathy due to granulomatous infiltration in patients with preserved ventricular function. , 2011, Journal of the American College of Cardiology.

[180]  William Weintraub,et al.  Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). , 2011, Journal of the American College of Cardiology.

[181]  Paul J. Wang,et al.  Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[182]  P. Kistler,et al.  Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. , 2011, Journal of the American College of Cardiology.

[183]  Michael O. Sweeney,et al.  Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial Results , 2004, Circulation.

[184]  D. Lin,et al.  New unipolar electrogram criteria to identify irreversibility of nonischemic left ventricular cardiomyopathy. , 2012, Journal of the American College of Cardiology.

[185]  Michael J. Ackerman,et al.  Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. , 2011, Journal of the American College of Cardiology.

[186]  N. Pandian,et al.  Pre-operative left atrial mechanical function predicts risk of atrial fibrillation following cardiac surgery. , 2011, JACC. Cardiovascular imaging.

[187]  G. Fonarow,et al.  Home monitoring for heart failure management. , 2012, Journal of the American College of Cardiology.

[188]  J. Deharo,et al.  Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block. , 2011, Journal of the American College of Cardiology.

[189]  Po-Cheng Chang,et al.  Epicardial ablation of rotors suppresses inducibility of acetylcholine-induced atrial fibrillation in left pulmonary vein-left atrium preparations in a beagle heart failure model. , 2011, Journal of the American College of Cardiology.

[190]  S. Colan,et al.  Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. , 2012, Journal of the American College of Cardiology.